Skip to main content

Sulfinpyrazone Pregnancy and Breastfeeding Warnings

Sulfinpyrazone is also known as: Anturane

Sulfinpyrazone Pregnancy Warnings

Sulfinpyrazone has not been assigned to an FDA pregnancy category. Animal teratogenicity studies of pyrazole compounds have resulted in inconclusive data. There are no data from controlled human pregnancy studies. Sulfinpyrazone should be given during pregnancy only when benefit outweighs risk.

See references

Sulfinpyrazone Breastfeeding Warnings

There are no data on the excretion of sulfinpyrazone into human milk.

See references

References for pregnancy information

  1. "Product Information. Anturane (sulfinpyrazone)." Novartis Pharmaceuticals (2001):

References for breastfeeding information

  1. Walton GD, Schreeder MT, Rizzo J, Jobe DR, Kuhn J "Hepatic artery administration of paclitaxel." Cancer Invest 17 (1999): 118-20

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.